收藏 分享
收录年代
序号 标题 作者 起始页 操作
1 Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20?mg twice daily or higher: A real‐world experience Naseema Gangat, Kristen McCullough, Aref Al‐Kali...
2 Sustained sutimlimab response for 3?years in patients with cold agglutinin disease: A phase I, open‐label, extension trial Georg Gelbenegger, Ulrich Jaeger, Michael Fillitz...
3 The clinical influence of preformed nonspecific anti‐HLA antibodies on single‐unit umbilical cord blood transplantation in patients with haematological malignancies Meijuan Tu, Xiang Wan, Wen Yao...
4 The impact of COVID‐19 on related‐donor allogeneic stem cell harvest processes: A British Society of Blood and Marrow Transplantation and Cellular Therapy survey Julia Wolf, Julia Lee, Rachel Pearce...
5 Heavy chain/light chain assay is a useful biomarker for diagnosis and management of patients with cold agglutinin disease Cindy Ursule‐Dufait, Djaouida Bengoufa, Ioannis Theodorou...
6 Issue Information 613
7 Pure erythroid leukaemia mimicking metastatic carcinoma Carballeira Seoane Laura, Facal Malvar Ana, Loyola Holgado Inés 617
8 Skin manifestations of intravascular adult T‐cell leukaemia/lymphoma Mitsuhito Ota, Sho Katayama, Tetsuya Hiraishi 618
9 Major haemorrhage: putting evidence into practice Jeannie Callum, Steven Tresierra, Thomas Woolley 619
10 New biomarker paves the way for a clinical trial for neurodegeneration in Langerhans cell histiocytosis Yoko Shioda, Kenichi Sakamoto, Akira Morimoto 623